<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">Our results are congruent with previous studies, showing that a higher prevalence of NCD comorbidities and risk factors among COVID-19 patients as well as greater risk for hospitalization (
 <xref rid="bib3" ref-type="bibr">3</xref>,
 <xref rid="bib4" ref-type="bibr">4</xref>,
 <xref rid="bib6" ref-type="bibr">6</xref>,
 <xref rid="bib8" ref-type="bibr">8</xref>,
 <xref rid="bib9" ref-type="bibr">9</xref>,
 <xref rid="bib14" ref-type="bibr">14</xref>,
 <xref rid="bib15" ref-type="bibr">15</xref>,
 <xref rid="bib19" ref-type="bibr">19</xref>). Hypertension and diabetes are the most prevalent NCDs in patients with COVID-19 in Mexico, and with CKD, pose the most significant risk of hospitalization. Among the reported modifiable risk factors, obesity also places a significant challenge on hospitalization. While diabetes and hypertension prevalence are higher among COVID-19 patients than in the general population, obesity is somewhat lower (
 <xref rid="bib11" ref-type="bibr">11</xref>).
</p>
